Table 3.
Funder | Grants | Country | Funding type |
---|---|---|---|
Genzyme Corp., USA | 220 | USA | Private, economic |
NIH, USA | 212 | USA | Public, government |
Shire HGT, USA | 133 | USA | Private, economic |
Amicus Therapeutics, USA | 29 | USA | Private, economic |
Japan Government | 29 | Japan | Public, government |
South Korea Government | 24 | South Korea | Public, government |
Canada Government | 18 | Canada | Public, government |
China Government | 17 | China | Public, government |
Brazil Government | 16 | Brazil | Public, government |
EU | 16 | International | Public, government |
Protalix Biotherapeutics, Israel | 16 | Israel | Private, economic |
Telethon Foundation, Italy | 15 | Italy | Private, foundation |
Italy Government | 14 | Italy | Public, government |
Spain Government | 14 | Spain | Public, government |